Alligator Bioscience AB (publ)

kr 0.01As of Sun 8 Nov 2026, 12:00 UTC
STO:ATORXHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (77.73%)
Div yield —
ROE (1178.95%)
Biotechnology
Beta (5Y) 1.30
PE TTM —
TSR TTM (99.38%)
Mkt cap kr 6.344M
ROIC (149.76%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 0.0103
1.72%
(84.23%)
Hold 4|5|6|12|4
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
—
—
—
—
9.18%
2.39%
(7.96%)
2.41%
Revenuekr M
0.543
0.543
0.576
0.575
2.27%
2.81%
2.91%
3.30%
Peers (US$0.641M)
Cap (US$)
PE
0.857M
—
Capital
TTM
5Y
10Y
Leveragex
3.636
0.694
0.679
EBIT/Intx
18.59
0.104
0.099
Own earn%
260.60
197.97
170.41
Sh yield%
25.85
17.09
18.64
Owners
Insiders/Inst%
7.69
29.52
Short interest%
2.24
SBC / revenue%
3.49
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
1–10
$1 testx
0.0
Incr. ROIC%
4